HK Stock MarketDetailed Quotes

PURAPHARM (01498)

Watchlist
  • 0.320
  • +0.025+8.47%
Market Closed May 8 15:51 CST
171.49MMarket Cap-4.85P/E (TTM)

PURAPHARM (01498) Revenue Breakdown Overview

By Business/Source

Currency:HKD
2025/FY
Stock NameRevenueRatio
Hong Kong concentrated Chinese medicine formula granules192.32M57.22%
Traditional Chinese medicine health care products92.56M27.54%
clinic51.24M15.24%
中国浓缩中药配方颗粒及种植1K0.00%

By Product

Currency:HKD
2025/FY
Stock NameRevenueRatio
Hong Kong concentrated Chinese medicine formula granules192.32M57.22%
Traditional Chinese medicine health care products92.56M27.54%
clinic51.24M15.24%
中国浓缩中药配方颗粒及种植1K0.00%

By Country/Region

Currency:HKD
2025/FY
Stock NameRevenueRatio
Hong Kong, China291.82M86.82%
Other countries / regions41.69M12.40%
The mainland of China2.61M0.78%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More